ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Illinois Legislature Votes Nearly $1 Million To ICC; Carolyne Davis Resigns From HCFA Jobs

August 2, 1985

NCI, ACS, Health Departments Launch ASSIST, Goal To Cut US Smoking Rate In Half By Yr 2000

October 11, 1991

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

Congress Provides 7% Increase For NIH, 6.6% for NCI, In FY98 Appropriation

November 14, 1997

Joe Gray Moves To OHSU Knight Cancer Institute

January 21, 2011